Reaching HbA1c goals with saxagliptin in combination with metformin or sulfonylurea

被引：0

作者：

Chen, R. ^{[1
]}

Xu, Z. ^{[1
]}

Duan, Y. ^{[1
]}

Apanovitch, A. ^{[1
]}

机构：

[1] Bristol Myers Squibb Co, Princeton, NJ USA

来源：

DIABETOLOGIA | 2009年 / 52卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

753

引用

页码：S296 / S296

页数：1

共 50 条

[1] Reaching HbA1c Goals with Saxagliptin in Combination with Other Oral Antidiabetic Drugs
LaSalle, James R.
[J]. POSTGRADUATE MEDICINE, 2010, 122 (01) : 144 - 152
[2] Saxagliptin (SAXA) Effectively Reduces HbA1c and Is Well Tolerated When Added to a Combination of Metformin (MET) and Sulfonylurea (SU)
Moses, Robert G.
Kalra, Sanjay
Brook, Debbie
Sockler, Jim
Visvanathan, Jayanti
Fisher, Simon A.
[J]. DIABETES, 2012, 61 : A282 - A282
[3] Effect of Sulfonylurea on HbA1c
Pavlicek, V.
[J]. DIABETOLOGE, 2013, 9 (05): : 403 - 403
[4] Analytical goals for HbA1c: Are HbA1c results good enough for optimal use?
Little, Randie R.
Rohlfing, Curt L.
[J]. JOURNAL OF DIABETES, 2011, 3 (01) : 3 - 6
[5] Efficacy and Safety of Vildagliptin in Triple Combination With Metformin Plus Sulfonylurea in Subgroup of Patients With T2DM and Baseline HbA1c
Lukashevich, Valentina
Araga, Mako
Kothny, Wolfgang
[J]. DIABETES, 2013, 62 : A294 - A294
[6] Saxagliptin in Combination with Metformin Allows More Patients To Reach a Composite End Point of HbA1c <7% without Weight Gain or Hypoglycemia
Horne, Laura
Ming, Eileen E.
Karyekar, Chetan
Donovan, Mark
Frederich, Robert
Ravichandran, Shoba
[J]. DIABETES, 2011, 60 : A620 - A620
[7] STATUS OF HBA1C MEASUREMENT AND GOALS FOR IMPROVEMENT
Little, R.
[J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S32 - S32
[8] COMPARISON OF HBA1C VARIABILITY BETWEEN SULFONYLUREA AND DPPIV INHIBITOR
Kim, Y. J.
Lee, E. J.
Kim, T. N.
Kim, T. K.
Kwon, M. J.
Park, J. H.
Rhee, B. D.
Kim, M. -K.
[J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S138 - S138
[9] Comparison of HBA1C With Sitagliptin Plus Metformin and Pioglitazone Plus Metformin
Bin Saeed, Saud
Idrees, Hifza
Haider, Hammad
[J]. PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2018, 12 (03): : 1248 - 1250
[10] Added value of diabetes risk genes to the prediction of HbA1c levels in patients initiating metformin or sulfonylurea derivatives
Martono, D.
Heerspink, H.
Hak, E.
Denig, P.
Wilffert, B.
[J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2018, 391 : S15 - S15

← 1 2 3 4 5 →